Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluation.

C. D. James, E. Galanis, L. Frederick, D. W. Kimmel, J. M. Cunningham, P. J. Atherton-Skaff, J. R. O'Fallon, R. B. Jenkins, J. C. Buckner, S. B. Hunter, J. J. Olson, B. W. Scheithauer

Research output: Contribution to journalArticle

40 Scopus citations

Abstract

We have examined a series of 135 gliomas for alterations of the p53, CDKN2A (p16) and PTEN tumor suppressor genes (TSGs) in order to evaluate the incidence of their inactivation as a function of tumor malignancy and cellular differentiation, and to examine potential associations with patient outcome. The composition of this series, classified using WHO criteria, is as follows: 27 grade 2 tumors (11 astrocytomas, 12 oligoastrocytomas, 4 oligodendrogliomas), 42 grade 3 tumors (22 astrocytomas, 16 oligoastrocytomas, 4 oligodendrogliomas), and 66 grade 4 tumors (63 astrocytomas and 3 oligoastrocytomas). Similar frequencies of p53 mutation were observed among grade 2 (37.0%), and grade 3 tumors (38.1%), as well as between astrocytomas and mixed tumors. CDKN2A and PTEN mutations were clearly associated with increasing tumor malignancy (occurring in 0% of grade 2 tumors, 14.3% and 4.8% respectively of grade 3 tumors, and 27.3% and 30.3% respectively of grade 4 tumors) and were observed at substantially higher rates among astrocytomas. For the tumor suppressor genes examined, there was no relationship between the occurrence of any two TSG inactivation events. With regard to outcome, the p53 genetic status showed no significant relationship with patient survival. The CDKN2 and PTEN alterations were negative prognostic indicators of survival when evaluated in all 135 gliomas, but failed to predict outcome when evaluated in either of the high grade (3 or 4) tumor groups.

Original languageEnglish (US)
Pages (from-to)547-553
Number of pages7
JournalInternational journal of oncology
Volume15
Issue number3
StatePublished - Sep 1999

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluation.'. Together they form a unique fingerprint.

  • Cite this

    James, C. D., Galanis, E., Frederick, L., Kimmel, D. W., Cunningham, J. M., Atherton-Skaff, P. J., O'Fallon, J. R., Jenkins, R. B., Buckner, J. C., Hunter, S. B., Olson, J. J., & Scheithauer, B. W. (1999). Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluation. International journal of oncology, 15(3), 547-553.